Multiple Sclerosis, Relapsing-Remitting - 31 Studies Found
Terminated |
: A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis : Multiple Sclerosis, Relapsing-Remitting : 2015-04-02 : Biological: Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the fla |
Completed |
: Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis : Multiple Sclerosis, Relapsing-Remitting : 2001-11-30 :
|
Withdrawn |
: Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis : Relapsing Remitting Multiple Sclerosis : 2015-05-11 :
|
Completed |
: Rebif® Rebidose® Versus Rebiject II® Ease-of-Use : Multiple Sclerosis, Relapsing-Remitting : 2013-12-18 :
|
Withdrawn |
: Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis : Relapsing Remitting Multiple Sclerosis : 2012-10-19 :
|